Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung condition characterised by chronic respiratory symptoms (dyspnea, cough, expectoration and/or exacerbations) due to abnormalities of the airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) that cause persistent, often progressive, airflow obstruction.
On the other hand, bronchiectasis (BE) is a clinical and radiological diagnosis associated with cough, sputum production and recurrent respiratory infections. COPD and BE clinically overlap in a variable (4-50%) proportion of patients, the presence of BE is associated with the severity of COPD, and both share some risk factors and mechanisms, such as dysbiosis and repeated infections, abnormal host immune response (neutrophilic/ eosinophilic presentations) and potential lung developmental abnormalities (dysanapsis), among others.
James Chalmers (UK)
Workshop Chair
Jadwiga Wedzicha (UK)
Workshop Chair
Oriol Sibila (ES)
Workshop Chair
Rosa Faner (ES)
Workshop Chair